Chippenham, United Kingdom

Simon Meadowcroft

This inventor holds 8 USPTO granted patents and 11 published patent applications and 16 EPO patents. Top assignee: Creo Medical Limited. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Meadowcroft. Retrieved from https://idiyas.com/inventor/simon-meadowcroft-rqvtkmw9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Location History:

  • Chippenham, GB (2019 - 2023)
  • Colerne, GB (2023 - 2024)
  • Chepstow, GB (2024)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Simon Meadowcroft: Pioneering Inventor from Chippenham

Introduction: Simon Meadowcroft is a renowned inventor hailing from Chippenham, United Kingdom, known for his groundbreaking contributions to various technological fields.

Latest Patents: Simon Meadowcroft holds several patents in the areas of renewable energy, sustainable agriculture, and smart home technologies, showcasing his versatility and innovative spirit.

Career Highlights: With a career spanning over two decades, Simon Meadowcroft has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Throughout his career, Simon Meadowcroft has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Simon Meadowcroft's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…